Unknown

Dataset Information

Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease.


ABSTRACT:

Background

The ACC/AHA cholesterol guidelines recommend patients with peripheral artery disease (PAD) be treated with a moderate to high-intensity statin. The extent to which patients with new or worsening PAD symptoms are offered guideline therapy is unknown.

Hypothesis

There is significant variability in rate of guideline-directed statin intensification across clinical practices.

Methods

In the PORTRAIT registry, patterns of statin therapy were assessed in 1144 patients at 16 PAD specialty clinics between June 2011 and December 2015 before and after an evaluation for new or worsening claudication symptoms. We documented whether patients were treated with a guideline statin as well as the incidence of statin intensification. Statin intensification was defined as tran

SUBMITTER: Khariton Y 

PROVIDER: S-EPMC6489902 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature